Disease

Adrenal Hormones and Disorders

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 27, 2026 · JOURNAL ARTICLE

Glucocorticoids as Adjunctive Therapy in Infectious Diseases—Immunomodulation in the Management of Infection-Related Inflammation

Private Practice Infectious Disease

A narrative review synthesizing evidence-based clinical indications for glucocorticoid adjunctive use across multiple infectious disease categories, grounded in RCTs and guidelines but not presenting new primary data.

Expert GuidanceRussell Petrak Adrenal Hormones and Disorders

AUG 13, 2026 · JOURNAL ARTICLE

How Common Is Hypercortisolism in Patients With Type 2 Diabetes? Risk Factors, Epidemiology, and Making a Diagnosis Using a Dexamethasone Suppression Test

Diabetes Obesity and Metabolism

A narrative review synthesizing current evidence on hypercortisolism in Type 2 diabetes, recommending targeted case-finding strategy and DST screening approach rather than universal screening.

Expert GuidanceHormonal Regulation and Hypertension Jenine Y. Stone Pituitary Gland Disorders and Treatments

Reported

Dexamethasone confirmatory level…≥140 ng/dL

AUG 9, 2026 · JOURNAL ARTICLE

Clinical Profile, Biochemical Characteristics, and Surgical Outcomes in Cushing Disease: An Age‐Stratified Analysis of a Large Tertiary‐Care Cohort

Clinical Endocrinology

Retrospective single-center observational audit without a comparator or control group, describing clinical and surgical outcomes in a tertiary-care cohort with acknowledged methodological limitations (no adjustment for multiple comparisons, unequal strata, non-uniform follow-up) that preclude causal inference.

PreliminaryRama Walia Kavyanjali Kundu Adrenal and Paraganglionic Tumors

Reported

Female predominance71.8%

Weight gain prevalence79.4%

Centripetal obesity prevalence62.5%